PCSK9 Drug Prevents First Heart Events in Diabetes Patients Without Atherosclerosis
(MedPage Today) -- NEW ORLEANS -- Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with ...
Tag: Atherosclerosis
(MedPage Today) -- NEW ORLEANS -- Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with ...